EV/EBITDA:
-63.44-2.28(-3.73%)Summary
- As of today (June 26, 2025), SPRY EV/EBITDA is -63.44, with a fall of -2.28 (-3.73%) during the current trading session.
- Over the past year, SPRY EV/EBITDA has dropped by -51.35 (-424.73%).
- SPRY EV/EBITDA is now -2358.91% below its all-time high of -2.58.
Performance
SPRY EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SPRY EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -3.7% | +3.7% | +3.6% |
| 1 m1 month | -20.0% | +20.0% | +19.4% |
| 3 m3 months | +83.5% | +44.9% | +42.0% |
| 6 m6 months | -276.5% | +68.4% | +60.5% |
| ytdytd | +80.5% | +71.2% | +69.6% |
| 1 y1 year | -424.7% | +136.2% | +121.4% |
| 5 y5 years | - | - | - |
SPRY EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -47.30 | -34.1% | -63.44 | at low |
| 3 m | 3-month | -42.43 | -49.5% | -385.49 | +83.5% |
| 6 m | 6-month | -16.71 | -279.6% | -456.94 | +86.1% |
| 1 y | 1-year | -11.88 | -434.0% | -456.94 | +86.1% |
| 3 y | 3-year | -2.58 | -2358.9% | -456.94 | +86.1% |
| 5 y | 5-year | -2.58 | -2358.9% | -456.94 | +86.1% |
| alltime | all time | -2.58 | -2358.9% | -456.94 | +86.1% |
SPRY EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -63.44(-80.5%) |
| 2024 | -325.40(+4685.3%) |
| Date | Value |
|---|---|
| 2023 | -6.80(-59.6%) |
| 2022 | -16.82 |
FAQ
- What is ARS Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for ARS Pharmaceuticals?
- What is SPRY EV/EBITDA year-to-date change?
- What is ARS Pharmaceuticals EV/EBITDA year-on-year change?
What is ARS Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SPRY is -63.44
What is the all time high EV/EBITDA for ARS Pharmaceuticals?
ARS Pharmaceuticals all-time high EV/EBITDA is -2.58
What is SPRY EV/EBITDA year-to-date change?
ARS Pharmaceuticals EV/EBITDA has changed by +261.96 (+80.50%) since the beginning of the year
What is ARS Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SPRY EV/EBITDA has changed by -51.35 (-424.73%)